JOURNAVX 50 mg/1
Suzetrigine · TABLET, FILM COATED · Vertex Pharmaceuticals Incorporated
No Recall History
Plain English
JOURNAVX is a tablet, film coated containing suzetrigine at 50 mg/1, taken oral. Manufactured by Vertex Pharmaceuticals Incorporated.
Key Facts
- Brand Name
- JOURNAVX
- Generic Name
- Suzetrigine
- NDC Code (Product)
51167-548- Manufacturer
- Vertex Pharmaceuticals Incorporated
- Strength
- 50 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA219209
- Drug Class
- Sodium Channel Blocker [EPC]
- Marketing Start
- 01/30/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is JOURNAVX used for?
JOURNAVX contains Suzetrigine. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is JOURNAVX a controlled substance?
JOURNAVX is not classified as a controlled substance by the DEA.
What is the generic name for JOURNAVX?
The generic name for JOURNAVX is Suzetrigine. There are no other listed brand versions of Suzetrigine.
What is the NDC code for JOURNAVX 50 mg/1?
The NDC (National Drug Code) for JOURNAVX 50 mg/1 is 51167-548, listed by Vertex Pharmaceuticals Incorporated.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)